Both in Pharmaceuticals

Sagimet Biosciences Inc. Series A vs Obsidian Therapeutics

Over the past year SGMT returned −8.2% and OBX returned −38.3%; their daily moves had a correlation of 0.37.

SGMT −8.2% OBX −38.3%Growth of $1, one year, split-adjusted
MetricSGMTOBX
Price$9.99$10.99
Market cap$708.4M$678.9M
Today+0.40%−16.93%
1 month+14.0%−16.9%
6 months+19.2%—
Year to date+68.8%—
1 year+23.9%—
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)——
Price / sales——
Net cash$240.1M—
Dividend yield——
Volatility (60d)73.1%—
Short % of float18.7%2.2%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

SGMT vs OBX: Sagimet Biosciences Inc. Series A vs Obsidian Therapeutics Stock Comparison | Gainbot